Richard Jones
Chief Executive Officer at AdrenoMed AG
Richard Jones active positions
Companies | Position | Start | End |
---|---|---|---|
AdrenoMed AG
AdrenoMed AG Pharmaceuticals: MajorHealth Technology AdrenoMed AG develops a drug to decrease mortality in severe sepsis. The company was founded by Bernd Wegener, Gerald Heinz Möller and Andreas Bergmann in 2009 and is headquartered in Berlin, Germany. | Chief Executive Officer | 2022-03-14 | - |
Career history of Richard Jones
Former positions of Richard Jones
Companies | Position | Start | End |
---|---|---|---|
FUSION ANTIBODIES PLC | Director/Board Member | 2021-02-15 | 2022-03-10 |
Chief Executive Officer | 2021-02-15 | 2022-03-10 | |
BrYet Ltd. | Director/Board Member | 2020-03-31 | 2020-06-30 |
Chief Executive Officer | 2020-03-31 | 2020-06-30 | |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - | - |
GSK PLC | Corporate Officer/Principal | - | - |
Novartis UK Ltd.
Novartis UK Ltd. Pharmaceuticals: MajorHealth Technology Novartis UK Ltd. is an international pharmaceutical company. It strives to discover ways to improve and extend people’s lives. The company is headquartered in Frimley, the United Kingdom. | Corporate Officer/Principal | - | - |
Holostem Terapie Avanzate S R L | Chief Executive Officer | - | - |
Akcea Therapeutics UK Ltd. | Corporate Officer/Principal | - | - |
Akinion Pharmaceuticals AB
Akinion Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Akinion Pharmaceuticals AB operates as a holding company that focuses on the development of pharmaceutical for the treatment of acute myeloid leukemia. It develops, markets, and sells a product based on Biovitrum’s anti leukemia kinase inhibitor research. It is a drug development that manufactures a lead candidate drug, AKN-028, which is a small molecule kinase inhibitor. The company was founded by Vendela Parrow in 2009 and is headquartered in Solna, Sweden. | Chief Executive Officer | 2016-01-26 | - |
Training of Richard Jones
University of Surrey | Doctorate Degree |
Statistics
International
United Kingdom | 7 |
United States | 2 |
Sweden | 2 |
Operational
Chief Executive Officer | 5 |
Corporate Officer/Principal | 4 |
Director/Board Member | 2 |
Sectoral
Health Technology | 6 |
Consumer Services | 2 |
Health Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 2 |
---|---|
GSK PLC | Health Technology |
FUSION ANTIBODIES PLC | Health Services |
Private companies | 7 |
---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Novartis UK Ltd.
Novartis UK Ltd. Pharmaceuticals: MajorHealth Technology Novartis UK Ltd. is an international pharmaceutical company. It strives to discover ways to improve and extend people’s lives. The company is headquartered in Frimley, the United Kingdom. | Health Technology |
Akinion Pharmaceuticals AB
Akinion Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Akinion Pharmaceuticals AB operates as a holding company that focuses on the development of pharmaceutical for the treatment of acute myeloid leukemia. It develops, markets, and sells a product based on Biovitrum’s anti leukemia kinase inhibitor research. It is a drug development that manufactures a lead candidate drug, AKN-028, which is a small molecule kinase inhibitor. The company was founded by Vendela Parrow in 2009 and is headquartered in Solna, Sweden. | Health Technology |
Akcea Therapeutics UK Ltd. | |
BrYet Ltd. | |
Holostem Terapie Avanzate S R L | |
AdrenoMed AG
AdrenoMed AG Pharmaceuticals: MajorHealth Technology AdrenoMed AG develops a drug to decrease mortality in severe sepsis. The company was founded by Bernd Wegener, Gerald Heinz Möller and Andreas Bergmann in 2009 and is headquartered in Berlin, Germany. | Health Technology |
- Stock Market
- Insiders
- Richard Jones
- Experience